Holen Sie sich die Stockscreener-App
15.55
1.33%
-0.21
Handel nachbörslich:
15.55
Schlusskurs vom Vortag:
$15.76
Offen:
$15.73
24-Stunden-Volumen:
201.84K
Relative Volume:
0.40
Marktkapitalisierung:
$631.57M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-168.05M
KGV:
-3.0312
EPS:
-5.13
Netto-Cashflow:
$-146.15M
1W Leistung:
+1.97%
1M Leistung:
+6.36%
6M Leistung:
+34.17%
1J Leistung:
-70.62%
1-Tages-Spanne:
$15.38
$15.73
1-Wochen-Bereich:
$14.97
$16.07
52-Wochen-Spanne:
$9.12
$72.37
Keros Therapeutics Inc Stock (KROS) Company Profile
Firmenname
Keros Therapeutics Inc
Sektor
Branche
Telefon
617-314-6297
Adresse
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA
Vergleichen Sie KROS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KROS
Keros Therapeutics Inc
|
15.55 | 638.47M | 0 | -168.05M | -146.15M | -5.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Keros Therapeutics Inc Stock (KROS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-10 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-01-21 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-01-17 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-12-16 | Bestätigt | Oppenheimer | Outperform |
| 2024-12-13 | Bestätigt | H.C. Wainwright | Buy |
| 2024-12-12 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-12-12 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-12-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-11-05 | Eingeleitet | Jefferies | Buy |
| 2024-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-09-23 | Eingeleitet | Guggenheim | Buy |
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-02-21 | Eingeleitet | William Blair | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-07-31 | Eingeleitet | Wedbush | Outperform |
| 2023-07-26 | Eingeleitet | BofA Securities | Buy |
| 2023-02-14 | Eingeleitet | Cowen | Outperform |
| 2022-10-18 | Eingeleitet | Truist | Buy |
| 2022-07-26 | Eingeleitet | BTIG Research | Buy |
| 2020-12-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-04 | Eingeleitet | Jefferies | Buy |
| 2020-05-04 | Eingeleitet | Piper Sandler | Overweight |
| 2020-05-04 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Keros Therapeutics Inc Aktie (KROS) Neueste Nachrichten
Charles Schwab Investment Management Inc. Reduces Stake in Keros Therapeutics, Inc. $KROS - MarketBeat
Technical signs of recovery in Keros Therapeutics Inc.Portfolio Update Summary & Safe Capital Growth Tips - Newser
What candlestick patterns are forming on Keros Therapeutics Inc.Weekly Profit Analysis & Real-Time Chart Pattern Alerts - Newser
How to escape a deep drawdown in Keros Therapeutics Inc.Analyst Upgrade & Weekly Watchlist of Top Performers - Newser
Real time alert setup for Keros Therapeutics Inc. performance - Newser
What MACD and RSI say about Keros Therapeutics Inc.2025 Trading Recap & Weekly Watchlist for Hot Stocks - Newser
Keros Therapeutics Inc. stock outlook for YEAR2025 Support & Resistance & Safe Entry Trade Signal Reports - Newser
What institutional flow reveals about Keros Therapeutics Inc.Quarterly Market Review & Smart Allocation Stock Tips - Newser
Short interest data insights for Keros Therapeutics Inc.Portfolio Profit Report & Weekly Top Performers Watchlists - Newser
Published on: 2025-09-03 02:58:10 - Newser
Tick level data insight on Keros Therapeutics Inc. volatilityJuly 2025 Outlook & Daily Momentum Trading Reports - Newser
Leading vs lagging indicators on Keros Therapeutics Inc. performanceJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
Can Keros Therapeutics Inc. lead its sector in growthMarket Activity Report & Accurate Trade Setup Notifications - khodrobank.com
Jump Financial LLC Acquires Shares of 103,826 Keros Therapeutics, Inc. $KROS - MarketBeat
Keros Therapeutics shares rise 1.46% after-hours following the release of DelveInsight's TGFB Inhibitor Pipeline Outlook 2025 report. - AInvest
Will Keros Therapeutics Inc. stock go up soonJuly 2025 Opening Moves & Expert Verified Stock Movement Alerts - Newser
Using AI based signals to follow Keros Therapeutics Inc.2025 Market Outlook & Fast Entry and Exit Trade Plans - Newser
Keros Therapeutics Inc. stock trend forecastPortfolio Return Report & Low Drawdown Trading Strategies - Newser
What is the target price for Keros Therapeutics Inc. stock2025 Year in Review & Fast Gaining Stock Reports - khodrobank.com
DRW Securities LLC Invests $4.74 Million in Keros Therapeutics, Inc. $KROS - MarketBeat
Does Keros Therapeutics Inc. stock have upside surprise potentialWeekly Earnings Recap & Stock Timing and Entry Methods - khodrobank.com
Intraday pattern recognizer results for Keros Therapeutics Inc.IPO Watch & Safe Capital Growth Trade Ideas - Newser
Keros Therapeutics, Inc. $KROS Shares Bought by Vanguard Group Inc. - MarketBeat
Analyzing Keros Therapeutics Inc. with risk reward ratio chartsTrade Analysis Report & Low Drawdown Trading Strategies - Newser
Real time breakdown of Keros Therapeutics Inc. stock performanceSwing Trade & Long-Term Safe Investment Ideas - Newser
Real time scanner hits for Keros Therapeutics Inc. explainedTrade Volume Summary & Safe Entry Zone Tips - Newser
Published on: 2025-09-01 15:43:13 - Newser
How to build a custom watchlist for Keros Therapeutics Inc.July 2025 Fed Impact & Accurate Buy Signal Notifications - Newser
Keros Therapeutics Inc. stock chart pattern explainedTrade Risk Report & Weekly Sector Rotation Insights - Newser
Published on: 2025-09-01 13:33:23 - Newser
Walleye Capital LLC Sells 47,163 Shares of Keros Therapeutics, Inc. $KROS - MarketBeat
Using RSI to spot recovery in Keros Therapeutics Inc.Market Rally & Verified Short-Term Plans - Newser
Published on: 2025-08-31 20:46:26 - Newser
Using RSI to spot recovery in Keros Therapeutics IncQuarterly Trade Review & Long-Term Safe Investment Ideas - Newser
Statistical indicators supporting Keros Therapeutics Inc.’s strength2025 Short Interest & Stock Market Timing Techniques - Newser
Pattern recognition hints at Keros Therapeutics Inc. upsideJuly 2025 Breakouts & Daily Technical Stock Forecast Reports - Newser
Is Keros Therapeutics Inc. stock entering bullish territoryMarket Trend Summary & Daily Profit Maximizing Trade Tips - Newser
Is Keros Therapeutics Inc. stock bottoming out2025 Valuation Update & High Yield Stock Recommendations - Newser
Keros Therapeutics Inc. recovery potential after sell offEarnings Trend Report & Low Risk Entry Point Tips - Newser
Finanzdaten der Keros Therapeutics Inc-Aktie (KROS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Keros Therapeutics Inc-Aktie (KROS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Seehra Jasbir | CHIEF EXECUTIVE OFFICER |
Apr 04 '25 |
Option Exercise |
0.30 |
49,367 |
14,810 |
302,223 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):